Our response to COVID-19

We're supporting people to maintain their wellbeing and manage isolation.

Treatments for bipolar II disorder

What is bipolar II disorder?

Bipolar II disorder is a common, recurrent, and disabling psychiatric illness. The lifetime incidence ranges from 1% to 11% depending on the method of diagnosis. DSM-IV defines bipolar II disorder as a lifetime history of at least one episode of major depression plus at least one episode of hypomania. By definition, individuals with bipolar II disorder never experience full-blown mania, unlike those with a diagnosis of bipolar I disorder. Bipolar II disorder is characterised by multiple and often protracted depressive episodes and a lower probability of returning to premorbid levels of functioning between episodes.

What is the evidence for treatments for bipolar II disorder?

Moderate to low quality evidence suggests the antipsychotic quetiapine may be an effective treatment for bipolar II depression. Low quality evidence is uncertain as to the benefits of other medications.

July 2020

Last updated at: 11:01 pm, 8th July 2020
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.